Loading quotes...

Forecast

The analysts' average price target is €111.27 (+6.05%). The median is €109.45 (+4.32%).

Buy
  10
Hold
  14
Sell
  2

Discussions in the community

There is no discussion about this asset yet.

Start discussion

  • agilon health raises EBITDA forecast: turnaround driven by contract discipline and clinical programs

    At the Jefferies conference, agilon health said the shift from growth to profitability is showing initial success and raised its 2026 EBITDA forecast to $75–95 million. Improved contract terms, a new data pipeline, tighter cost control and advanced clinical programs—especially for heart failure—contributed to better risk-adjusted and cost outcomes. The company closed Q2 with $257 million in cash (excluding ACO units) and expects at least $125 million by year-end, but remains cautious due to medical cost sensitivity to small variances. » More on de.investing.com


  • Agilon Health significantly beats Q2 expectations and raises full‑year outlook

    Agilon Health reported adjusted earnings of $1.04 per share in Q2 2026 (expectation $0.08) and revenue of $1.49 billion (expectation $1.44 billion), and subsequently raised its full‑year guidance for revenue, medical margin and adjusted EBITDA. The medical margin rose to $197 million and adjusted EBITDA to $70 million, despite a deliberate 12.3% reduction in Medicare Advantage membership. Management attributes the strong results to stricter contract discipline, improved risk adjustments and favorable cost trends. The stock jumped sharply and the company now expects about $5.8 billion in revenue and roughly $85 million of adjusted EBITDA for 2026. » More on de.investing.com

Financials

In the last quarter, Agilon Health Inc had revenue of €1.34B and net profit of €30.82M
(EUR) September 2026
YoY
Revenue 1.34B 9.68%
Gross profit 86.5M 250.07%
Net profit 30.82M 132.82%
EBITDA 41.84M 148.49%

Fundamentals

Metric Value
Market capitalization
€1.76B
Number of shares
16.8M
52-week high/low
€120.84 - €6.79
Dividends No
Beta
3.11
P/E ratio
-17.66
PEG ratio
-0.30
P/B ratio
6.92
P/S ratio
0.32

Company profile

Name
Agilon Health Inc
CEO
Timothy O'Rourke
Employees 856
🍪

Parqet  uses cookies. Learn more